SUTRO BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-93.9M | — |
| FY2016 | — | $-90.9M | $11.6M |
| FY2017 | — | $-109.0M | $22.0M |
| FY2018 | $10.0M | $131.5M | $125.3M |
| FY2019 | $8.9M | $97.8M | $5.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-93.9M | — |
| FY2016 | — | $-90.9M | $11.6M |
| FY2017 | — | $-109.0M | $22.0M |
| FY2018 | $10.0M | $131.5M | $125.3M |
| FY2019 | $8.9M | $97.8M | $5.0M |